{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-027135","form_type":"8-K","ticker":"ERNA","cik":"0000748592","company_name":"Ernexa Therapeutics Inc.","filed_at":"2022-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.071666+00:00","generated_at":"2026-06-24T08:24:08.400416+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Brooklyn ImmunoTherapeutics CSO Kevin D'Amour resigns; effective date TBD","bullets":["Dr. Kevin D'Amour, Chief Scientific Officer, submitted resignation notice on July 21, 2022.","Effective date of resignation not yet determined by the Company and Dr. D'Amour.","No successor or interim CSO announced in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-027135","json":"https://secwatch.observer/filing/0001140361-22-027135.json","markdown":"https://secwatch.observer/filing/0001140361-22-027135.md","text":"https://secwatch.observer/filing/0001140361-22-027135.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/748592/000114036122027135/0001140361-22-027135-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/748592/000114036122027135/brhc10040035_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T08:24:08.400416+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fb4cb4b67b","claim":"Dr. Kevin D'Amour resigned as Chief Scientific Officer at Ernexa Therapeutics Inc..","evidence_excerpt":"On July 21, 2022, Dr. Kevin D’Amour, Chief Scientific Officer of Brooklyn ImmunoTherapeutics, Inc., a Delaware corporation (the “ Company ”), delivered his notice of resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/748592/000114036122027135/0001140361-22-027135-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Scientific Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}